Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.24%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +33.98%
#5 Humanity Humanity +28.27%
#6 Codatta Codatta +19.36%
#7 Walrus Walrus +17.42%
#8 Enso Enso +17.35%
#9 The Black Bull The Black Bull +14.68%
#10 Collector Crypt Collector Crypt +14.46%
Coin of the day
EXOD EXOD
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Hybrigenics S.A. Hybrigenics S.A.

Hybrigenics S.A.

ALHYG
Kedudukan dalam Saham #36421
Hybrigenics SA is a biotechnology firm, along with its subsidiaries,... Hybrigenics SA is a biotechnology firm, along with its subsidiaries, headquartered in Gallargues-le-Montueux, France. The company specializes in pioneering biotechnological advancements, particularly within oncology, regenerative medicine, and anti-aging therapies. Additionally, Hybrigenics is actively involved in developing technical solutions that leverage adipose tissue cells and stem cells. It operates as a subsidiary of Diagnostic Medical Systems S.A.
Harga Saham
$0.01155578
Disegerakkan terakhir: 2024-07-16
Modal Pasaran
$2.70M
Perubahan (1 hari)
2.98%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Hybrigenics S.A. (ALHYG)

Kategori

Healthcare
Hasil untuk Hybrigenics S.A. (ALHYG)
Hasil pada Dec 2023 TTM: $424.28K
Menurut laporan kewangan terkini daripada Hybrigenics S.A., hasil semasa syarikat (TTM) ialah $424.28K. Pada tahun 2022, syarikat memperoleh hasil sebanyak $1.67K penurunan berbanding hasil pada tahun 2021 iaitu $167.31K. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Hybrigenics S.A. dari 2009 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $424.28K 0.00%
2023 $424.28K 25,254.72%
2022 $1.67K -99.00%
2021 $167.31K -8.79%
2020 $183.44K -30.41%
2019 $263.58K 198.93%
2018 $88.18K -96.09%
2017 $2.26M -40.55%
2016 $3.79M -24.61%
2015 $5.03M -25.04%
2014 $6.71M -13.16%
2013 $7.73M 28.05%
2012 $6.04M 106.82%
2011 $2.92M -41.54%
2010 $4.99M -16.46%
2009 $5.98M 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 2,975,379.11%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 1,419,084.80%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 2,382,957.64%
BE